Scarica l'app Stockscreener
3.13
6.29%
-0.21
Dopo l'orario di chiusura:
3.22
0.09
+2.88%
Precedente Chiudi:
$3.34
Aprire:
$3.35
Volume 24 ore:
18,111
Relative Volume:
0.80
Capitalizzazione di mercato:
$26.10M
Reddito:
$7.50M
Utile/perdita netta:
$-9.85M
Rapporto P/E:
-2.264
EPS:
-1.3825
Flusso di cassa netto:
$-24.56M
1 W Prestazione:
+2.62%
1M Prestazione:
+1.79%
6M Prestazione:
-0.95%
1 anno Prestazione:
+8.68%
Intervallo 1D:
$3.0575
$3.40
Intervallo di 1 settimana:
$2.97
$3.40
Portata 52W:
$2.52
$12.15
Evaxion A S Adr Stock (EVAX) Company Profile
Compare EVAX vs VRTX, REGN, ARGX, RVMD, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EVAX
Evaxion A S Adr
|
3.13 | 27.86M | 7.50M | -9.85M | -24.56M | -1.3825 |
VRTX
Vertex Pharmaceuticals Inc
|
515.55 | 128.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
805.93 | 82.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
987.84 | 53.26B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
212.00 | 43.66B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
362.51 | 39.31B | 5.76B | 514.49M | 1.10B | 4.4813 |
Evaxion A S Adr Stock (EVAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-19 | Iniziato | Maxim Group | Buy |
| 2024-04-02 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2024-02-12 | Iniziato | H.C. Wainwright | Buy |
Evaxion A S Adr Borsa (EVAX) Ultime notizie
Evaxion Biotech A/S Adr (EVAX) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1 - GlobeNewswire Inc.
European ADRs Rose As Biopharma Names Led The Pack - Finimize
US-Traded European Stocks Slipped As Arm And ArcelorMittal Fell - Finimize
Evaxion A/S Sponsored ADR Actuals & Estimates (NASDAQ:EVAX) - TradingView
European ADRs Edged Higher As Biotech Led Friday’s Moves - Finimize
Evaxion receives Prix Galien UK Award for Best digital health solution - Finansavisen
Evaxion presents new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia - Finansavisen
European ADRs Started The Week In The Green - Finimize
European ADRs Edged Higher In US Trading - Finimize
EVAXEvaxion A/S ADR Options - Finviz
Evaxion Biotech Signals Strong R&D Momentum Amid Cash Constraints - TipRanks
Evaxion promotes Birgitte Rønø to joint role of Chief Scientific and Chief Operating Officer - Finansavisen
Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial - Finansavisen
Evaxion concludes Annual General Meeting - Finansavisen
Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01 - Finansavisen
Endesa S.A. – Unsponsored ADR (OTCMKTS:ELEZY) Given Average Rating of “Strong Sell” by Brokerages - Defense World
Experience real-time quotes, in-depth charts, and analyst ratings - webull.com
Notice to convene Evaxion’s Annual General Meeting - Finansavisen
Europe’s US-Listed ADRs Rose, Led By Solar And Biotech - Finimize
European ADRs Rose, While Biotech Names Did The Heavy Lifting - Finimize
Evaxion Biotech Earnings Call Highlights AI and Runway - TipRanks
Evaxion A/S (NASDAQ:EVAX) Receives Buy Rating from HC Wainwright - Defense World
Evaxion A/S (NASDAQ:EVAX) Price Target Cut to $9.00 by Analysts at Lake Street Capital - Defense World
Evaxion Earnings Report: Q4 Overview - Sahm
Evaxion A/S – Sponsored ADR (NASDAQ:EVAX) Short Interest Up 20.9% in February - Defense World
Evaxion Biotech's Earnings: A Preview - Sahm
European ADRs Slip Slightly As Winners And Losers Split - Finimize
European Biotech Stocks Outperformed As Broader Market Dipped - Finimize
European Pharma And Biotech Companies Led ADR Gains In The US - Finimize
Analysts Are Bullish on Top Healthcare Stocks: Evaxion Biotech (EVAX), Azitra Inc (AZTR) - The Globe and Mail
Evaxion Stock Climbs Amid Biotech Surge - StocksToTrade
Evaxion Biotech A/S Announces Change in American Depositary Shares Ratio to Enhance Liquidity - nasdaq.com
Evaxion A/S (EVAX) Stock Forecast and Price Target 2026 - MarketBeat
Why Is Cancer Therapy Focused Evaxion Biotech Stock Trading Higher Today? - Sahm
symbol__ Stock Quote Price and Forecast - CNN
Evaxion Biotech (EVAX) Profile, Company FAQs & Facts, Industry, Sector, Employee Strength - Stocktwits
What is the current Price Target and Forecast for Evaxion A/SSponsored ADR (EVAX) - Zacks Investment Research
Top movers in Friday's pre-market session - ChartMill
Evaxion Biotech (EVAX) Stock Price Soared 236.9% Premarket Amid Buying Pressure - AskTraders
Top movers in Wednesday's after hours session - ChartMill
Evaxion A/S (EVAX) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
Evaxion A/S (EVAX) Institutional Ownership 2026 - MarketBeat
Evaxion A S Adr Azioni (EVAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.80%
1.77%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):